Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR2F2 | P24468 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 6/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.36 |
| ▸ | SCN9A | Q15858 | 3/20 | 0.35 |
| ▸ | BRD4 | O60885 | 1/20 | 0.35 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 4/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3617492 | 0.87 | L3MBTL1 (0.39) | LMNASMN1; SMN2TSHRCYP1A2CYP2C9 | |
| SCHEMBL3609386 | 0.86 | SMN1; SMN2 (0.38) | LMNASMN1; SMN2TSHRCYP1A2CYP2C9 | |
| SCHEMBL3602126 | 0.83 | KMT2A (0.38) | NR2F2LMNASMN1; SMN2TSHRMAPT | |
| SCHEMBL3607949 | 0.82 | SMN1; SMN2 (0.35) | LMNASMN1; SMN2SCN9ASCN5ATSHR | |
| SCHEMBL3607161 | 0.76 | SMN1; SMN2 (0.40) | NR2F2SMN1; SMN2CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL3606304 | 0.75 | PPOX (0.40) | LMNASMN1; SMN2TSHRCYP1A2CYP2C9 | |
| SCHEMBL3612119 | 0.75 | SMN1; SMN2 (0.36) | NR2F2SMN1; SMN2CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL3609770 | 0.75 | SMN1; SMN2 (0.37) | NR2F2SMN1; SMN2CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL3608916 | 0.75 | KDM4E (0.39) | NR2F2SMN1; SMN2TSHRCYP1A2CYP2C9 | |
| SCHEMBL3605072 | 0.75 | KDM4E (0.39) | NR2F2SMN1; SMN2TSHRCYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100016396-A1 | PYRAZOLE COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-01-21 | — | — | US | disclosed |
| EP-2128138-A1 | PYRAZOLE COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2009-12-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100016396-A1 | PYRAZOLE COMPOUND | SLC5A1, SLC5A2, GLP1R | NR2F2 3834/4885LMNA 4306/4885SMN1; SMN2 4515/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.